Gold nanoparticles
Gold nanoparticles as a novel
platform for development and
delivery of influenza vaccines.
(Image Credit: Wenqian Tao)
Confocal image of pollens
Plant pollens and spores as
a novel platform for oral
delivery of vaccines.
(Image Credit: Yunzhe Ma)
Microneedle array
Painless microneedles for
vaccine and drug delivery to various
tissues of the human body.
(Image Credit: Harvinder Gill)
SEM of pollens
Plant pollens and spores as
a novel platform for oral
delivery of vaccines.
(Image Credit: Yunzhe Ma)
Oral cavity histology
Microneedles for local delivery
of cancer medications to
oral cavity for management of
oro-pharyngeal tumors.
(Image Credit: Yunzhe Ma)

Welcome to Gill Laboratory

Gill Laboratory is directed by Dr. Harvinder Gill. Dr. Gill and his colleagues in the laboratory perform fundamental and translational research in the fields of drug delivery, vaccines, immunology, and nanomedicine to help address some of the pressing biomedical challenges facing human health. Our research integrates the knowledge and tools from various disciplines including engineering, chemistry, biology, immunology, recombinant engineering, and micro-nano-technology.

Research

Gill Laboratory is currently developing various innovative drug and vaccine delivery platforms. The vaccine delivery systems are aimed to maximize stimulation of mucosal immunity and are directed to address the challenges related to influenza and HIV infectious diseases. We are also developing a delivery system for localized delivery of cancer drugs directly into oral tumors that could potentially improve prognosis in patients of head and neck tumors. Importantly the approach could minimize surgical organ loss associated with head and neck tumors.

We are pioneering the use of plant pollens/spores as vaccination systems. We are also harnessing the powerful potential of gold nanoparticles, microneedles and recombinantly synthesized proteins as basis for our delivery systems.